Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses.
Abd Hamid M, Wang RZ, Yao X, Fan P, Li X, Chang XM, Feng Y, Jones S, Maldonado-Perez D, Waugh C, Verrill C, Simmons A, Cerundolo V, McMichael A, Conlon C, Wang X, Peng Y, Dong T.
Abd Hamid M, et al.
Cancer Immunol Res. 2019 Aug;7(8):1293-1306. doi: 10.1158/2326-6066.CIR-18-0885. Epub 2019 Jun 18.
Cancer Immunol Res. 2019.
PMID: 31213473